EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Placental histopathology in early-onset fetal growth restriction with use of sildenafil, a secondary analysis of the Dutch STRIDER study

Marjon E Feenstra, Mirthe H Schoots, Romy Bezemer, Lotte-Elisabeth van der Meeren, Peter Gj Nikkels, Harry van Goor, Jan-Luuk Hillebrands, Jelmer R Prins, Wessel Ganzevoort, Sanne J Gordijn

Placenta · 2025

DOI: 10.1016/j.placenta.2024.10.024 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Placenta, 2025. Verfasst von Marjon E Feenstra und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic addres…. Hauptthemen laut MEDLINE: Sildenafil Citrate, Fetal Growth Retardation, Placenta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Placental pathology lesions are common in early-onset fetal growth restriction (eoFGR). Therapeutic interventions to improve eoFGR outcomes are needed. In the international STRIDER trials (Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction) sildenafil didn't improve perinatal outcomes of eoFGR. We aimed to study the underlying placental pathology in the Dutch STRIDER trial and the effects of sildenafil on placental histopathology by describing the associations with sildenafil treatment, placental-dysfunction serum biomarkers and markers of oxidative stress. METHODS: The Dutch STRIDER trial was a randomized controlled trial of sildenafil versus placebo in 216 singleton pregnancies complicated by eoFGR, included between 20+0- and 29+6-weeks' gestation. In 158 cases, placental histology was available. Lesions were classified independently by three perinatal pathologists blinded for clinical data, according to the international criteria of the Amsterdam Placental Workshop Group Consensus Statement. Blood samples taken at inclusion were analyzed for free thiols (FT), placental growth factor (PlGF) and soluble FMS-like tyrosine kinase-1 (sFlt-1, n = 85). RESULTS: The 'big four' placental lesions (maternal and fetal vascular malperfusion, and chronic or acute inflammatory lesions) were equally distributed in both groups. However, massive perivillous fibrin deposition (MPFD) and chronic histiocytic intervillositis (CHIV) were less common in the sildenafil-treated group compared to the placebo-treated group (p = 0.026 and p = 0.043). FT, PlGF and sFlt-1 at inclusion were not discriminative for placental lesions. CONCLUSIONS: Sildenafil had no effect on common placental lesions. The lower incidence of MPFD and CHIV after sildenafil exposure merits more research on the interaction between sildenafil and the immune system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sildenafil CitrateFetal Growth RetardationPlacentaHumansPregnancyFemaleAdultNetherlands

Stichwörter der Autor:innen

Maternal vascular malperfusionPlacental pathologySildenafileoFGR

Substanzen

Sildenafil Citrate

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: m.e.feenstra@umcg.nl.
  • Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Department of Obstetrics and Gynaecology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands; Department of Pathology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Department of Obstetrics and Gynaecology, Amsterdam University Medical Center, Amsterdam, the Netherlands; Amsterdam Reproduction & Development Research Institute, Amsterdam, the Netherlands.

Förderung

  • ZonMw

Zitieren

APA

Feenstra, M. E., Schoots, M. H., Bezemer, R., van der Meeren, L. E., Nikkels, P. G., Goor, H. V., Hillebrands, J. L., Prins, J. R., Ganzevoort, W., & Gordijn, S. J. (2025). Placental histopathology in early-onset fetal growth restriction with use of sildenafil, a secondary analysis of the Dutch STRIDER study. Placenta. https://doi.org/10.1016/j.placenta.2024.10.024

Vancouver

Feenstra ME, Schoots MH, Bezemer R, van der Meeren LE, Nikkels PG, Goor HV, et al. Placental histopathology in early-onset fetal growth restriction with use of sildenafil, a secondary analysis of the Dutch STRIDER study. Placenta. 2025. doi:10.1016/j.placenta.2024.10.024

BibTeX
@article{Feenstra2025,
  author = {Feenstra, Marjon E and Schoots, Mirthe H and Bezemer, Romy and van der Meeren, Lotte-Elisabeth and Nikkels, Peter Gj and Goor, Harry van and Hillebrands, Jan-Luuk and Prins, Jelmer R and Ganzevoort, Wessel and Gordijn, Sanne J},
  title = {Placental histopathology in early-onset fetal growth restriction with use of sildenafil, a secondary analysis of the Dutch STRIDER study},
  journal = {Placenta},
  year = {2025},
  doi = {10.1016/j.placenta.2024.10.024}
}
Kostenlos starten →